Lisa LeCointe-Cephas - May 1, 2023 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
SVP Chief Ethics & Com Officer
Signature
/s/ Kelly E. W. Grez as attorney-in-fact for Lisa LeCointe-Cephas
Stock symbol
MRK
Transactions as of
May 1, 2023
Transactions value $
$48,728
Form type
4
Date filed
5/3/2023, 03:11 PM
Previous filing
May 5, 2022
Next filing
May 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Options Exercise $74.2K +643 +17.23% $115.47 4.38K May 1, 2023 Direct
transaction MRK Common Stock Tax liability -$25.5K -221 -5.05% $115.47 4.15K May 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Restricted Stock Unit Options Exercise $0 -643 -100% $0.00* 0 May 1, 2023 Common Stock 643 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.